Detection of Lung Cancer and EGFR Mutation by Electronic Nose System

Journal of Thoracic Oncology

Volumn 12, Issue 10, 2017, Pages 1544-1551

  Shlomi, Dekel ^a   Abud, Manal ^b   Liran, Ori ^c   Bar, Jair ^c   Gai Mor, Naomi ^c   Ilouze, Maya ^c   Onn, Amir ^c   Ben Nun, Alon ^c   Haick, Hossam ^b   Peled, Nir ^c,d  

^a CLALIT HEALTH SERVICES   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

Electronic nose; Lung cancer; Pulmonary nodule; Sensor; Volatile organic compound

Indexed keywords

NANOMATERIAL; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; BREATH ANALYSIS; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EGFR GENE; ELECTRONIC NOSE; FEMALE; GENE; GENE MUTATION; HUMAN; LUNG CANCER; LUNG LESION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NANOARRAY; PATTERN RECOGNITION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; AGED; EARLY CANCER DIAGNOSIS; GENETICS; LUNG TUMOR; MUTATION; PROCEDURES; PROGNOSIS; UTILIZATION;

AGED; BREATH TESTS; EARLY DETECTION OF CANCER; ELECTRONIC NOSE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 85028088897     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2017.06.073     Document Type: Article

References (34)

1. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
2. National Institutes of Health National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER cancer statistics review, 1975-2010. https://seer.cancer.gov/archive/csr/1975_2010/. Accessed August 14, 2017.
3. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
4. Wiener, R.S., Gould, M.K., Woloshin, S., Schwartz, L.M., Clark, J.A., What do you mean, a spot? A qualitative analysis of patients’ reactions to discussions with their physicians about pulmonary nodules. Chest 143 (2013), 672–677.
5. Shlomi, D., Ben-Avi, R., Balmor, G.R., Onn, A., Peled, N., Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J 44 (2014), 217–238.
6. Pauling, L., Robinson, A.B., Teranishi, R., Cary, P., Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 68 (1971), 2374–2376.
7. Konvalina, G., Haick, H., Sensors for breath testing: from nanomaterials to comprehensive disease detection. Acc Chem Res 47 (2014), 66–76.
8. Buszewski, B., Kesy, M., Ligor, T., Amann, A., Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr 21 (2007), 553–666.
9. Hakim, M., Broza, Y.Y., Barash, O., et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev 112 (2012), 5949–5966.
10. Amann, A., Mochalski, P., Ruzsanyi, V., Broza, Y.Y., Haick, H., Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties. J Breath Res, 8, 2014, 016003.
11. Haick, H., Broza, Y.Y., Mochalski, P., Ruzsanyi, V., Amann, A., Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev 43 (2014), 1423–1449.
12. Phillips, M., Herrera, J., Krishnan, S., Zain, M., Greenberg, J., Cataneo, R.N., Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 729 (1999), 75–88.
13. Mazzone, P.J., Hammel, J., Dweik, R., et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 62 (2007), 565–568.
14. Schumer, E.M., Trivedi, J.R., van Berkel, V., High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds. J Thorac Cardiovasc Surg 150 (2016), 1517–1524.
15. Broza, Y.Y., Haick, H., Nanomaterial-based sensors for detection of disease by volatile organic compounds. Nanomedicine (Lond) 8 (2013), 785–806.
16. Peng, G., Hakim, M., Broza, Y.Y., et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 103 (2010), 542–551.
17. Peng, G., Tisch, U., Adams, O., et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 4 (2009), 669–673.
18. Peng, G., Trock, E., Haick, H., Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. Nano Lett 8 (2008), 3631–3635.
19. Dragonieri, S., Annema, J.T., Schot, R., et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64 (2009), 166–170.
20. Machado, R.F., Laskowski, D., Deffenderfer, O., et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 171 (2005), 1286–1291.
21. Tisch, U., Haick, H., Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Reviews in Chemical Engineering 26 (2011), 171–179.
22. Tisch, U., Haick, H., Nanomaterials for cross-reactive sensor arrays. MRS Bull 35 (2010), 797–803.
23. Hakim, M., Billan, S., Tisch, U., et al. Diagnosis of head-and-neck cancer from exhaled breath. Br J Cancer 104 (2011), 1649–1655.
24. Barash, O., Peled, N., Tisch, U., Bunn, P.A. Jr., Hirsch, F.R., Haick, H., Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine 8 (2012), 580–589.
25. Peled, N., Hakim, M., Bunn, P.A. Jr., et al. Non-invasive breath analysis of pulmonary nodules. J Thorac Oncol 7 (2012), 1528–1533.
26. Tan, J.L., Yong, Z.X., Liam, C.K., Using a chemiresistor-based alkane sensor to distinguish exhaled breaths of lung cancer patients from subjects with no lung cancer. J Thorac Dis 8 (2016), 2772–2783.
27. Peralbo-Molina, A., Calderón-Santiago, M., Priego-Capote, F., Jurado-Gámez, B., Luque de Castro, M.D., Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate. J Breath Res, 10, 2016, 26002.
28. Peled, N., Barash, O., Tisch, U., Ionescu, R., Broza, Y.Y., Volatile fingerprints of cancer specific genetic mutations. Nanomedicine 9 (2013), 758–766.
29. Davies, M.P.A., Barash, O., Jeries, R., et al. Unique volatolomic signatures of TP53 and KRAS in lung cells. Br J Cancer 111:6 (2014), 1213–1221.
30. Handa, H., Usuba, A., Maddula, S., Baumback, J.I., Mineshita, M., Miyazawa, T., Exhaled breath analysis for lung cancer detection using ion mobility spectrometry. PLoS One, 9, 2014, e114555.
31. Dovgolevsky, E., Haick, H., Direct observation of the transition point between quasi-spherical and cubic nanoparticles in a two-step seed-mediated growth method. Small 4 (2008), 2059–2066.
32. Dovgolevsky, E., Tisch, U., Haick, H., Chemically sensitive resistors based on monolayer-capped cubic nanoparticles: towards configurable nanoporous sensors. Small 5 (2009), 1158–1161.
33. Amal, H., Leja, M., Funka, K., et al. Breath testing as potential colorectal cancer screening tool. Int J Cancer 138 (2016), 229–236.
34. Amal, H., Leja, M., Funka, K., et al. Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut 65:3 (2016), 400–407.